secwatch.observer — SEC 8-K summary
======================================

Issuer:     Baudax Bio, Inc. (—)
CIK:        0001780097
Form:       8-K
Filed at:   2023-10-06T23:59:59+00:00
Accession:  0001193125-23-251966
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Baudax Bio Corporate Controller resigns; appoints Interim CFO via Danforth
--------------------------------------------------------------------------

- Jillian Dilmore resigns as Corporate Controller, PFO, PAO, and Corporate Secretary effective Oct 9, 2023; she will provide continued consulting support.
- Board appoints Natalie McAndrew as Interim CFO effective Oct 9, 2023; she will also serve as PFO and PAO through Danforth Advisors.
- McAndrew, age 49, is a Director at Danforth Advisors, a life science advisory firm; no family relationships with executives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1780097/000119312523251966/0001193125-23-251966-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1780097/000119312523251966/d416304d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-251966

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer